Search
Type 2 Diabetes Paid Clinical Trials in South Dakota
A listing of 3 Type 2 Diabetes clinical trials in South Dakota actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 3 of 3
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
Type 2 Diabetes
Filter by Age
Filter by Type
Gender
Type of Study
Clinical Trial Phase
The state of South Dakota currently has 3 active clinical trials seeking participants for Type 2 Diabetes research studies. These trials are conducted in various cities, including Sioux Falls, Rapid City, Aberdeen and Watertown.
Featured Trial
Heart Failure Risk w/ T2DM Clinical Study
Recruiting
We are actively recruiting for a clinical study aimed at reducing the risk of heart failure events and cardiovascular-related deaths, such as heart attack, stroke, or hospitalization due to worsening heart failure.
Find out if you qualify.
Find out if you qualify.
Conditions:
Heart Failure Risk w/ T2DM
Heart Failure
Congestive Heart Failure
Chronic Heart Failure
Heart Failure
Featured Trial
Type 2 Diabetes (Hard-to-Control) Clinical Study
Recruiting
Studying an Investigational Medication for Adults with Hard-to-Control Type 2 Diabetes.
We're reaching out to let you know that a type 2 diabetes study is looking for participants to help advance investigational weight management treatment options.
Participants who qualify and enroll may receive compensation for related time and travel.
We're reaching out to let you know that a type 2 diabetes study is looking for participants to help advance investigational weight management treatment options.
Participants who qualify and enroll may receive compensation for related time and travel.
Conditions:
Type 2 Diabetes (Hard-to-Control)
Diabetes Mellitus
Type 2
Type 2 Diabetes
Diabete Type 2
Featured Trial
Diabetic Pain Study Clinical Study
Recruiting
Do you have diabetes and pain in your lower legs? Clinical trials are running for participants experiencing pain associated with diabetes.
Conditions:
Diabetic Pain Study
Diabetic
Diabetes
Diabetes Mellitus
Type 2
Featured Trial
Obesity w/ CVD or T2DM Clinical Study
Recruiting
We are actively recruiting patients who are interested in participating in an obesity clinical trial. The main purpose of this study is to evaluate the cardiovascular safety of the investigational weight loss medication compared with a placebo in participants who are at an increased risk of adverse cardiovascular outcomes (ie. heart attack and stroke)..
Conditions:
Obesity w/ CVD or T2DM
Obesity
Overweight and Obesity
Morbid Obesity
Obesity
Featured Therapy
Unique Treatment for High Blood Pressure
Worried about high blood pressure? Think beyond typical high blood pressure treatments.
People who may be candidates for this procedure:
• Are at least 18 years old
• Have been unable to manage their high blood pressure with medications or lifestyle changes alone¹
Learn about a safe and effective procedure that may help reduce high blood pressure. See if you qualify today.
¹ Kandzari DE, et al. J Am Coll Cardiol. Nov 7, 2023;82(19):1809-1823.
People who may be candidates for this procedure:
• Are at least 18 years old
• Have been unable to manage their high blood pressure with medications or lifestyle changes alone¹
Learn about a safe and effective procedure that may help reduce high blood pressure. See if you qualify today.
¹ Kandzari DE, et al. J Am Coll Cardiol. Nov 7, 2023;82(19):1809-1823.
Conditions:
High Blood Pressure
High Blood Pressure (& [Essential Hypertension])
High Blood Pressure (Hypertension).
Hypertension
Essential Hypertension
Featured Trial
Reduce Heart Failure Risk – See if You Qualify for a Study
Recruiting
We are currently looking for individuals aged 18 and older to take part in a heart disease research study. You may be eligible if you have been diagnosed with all of the following:
• Cardiovascular Disease
• Type 2 Diabetes
• High Blood Pressure
This study is exploring an investigational medication that may help reduce the risk of heart-related complications.
If you’re interested in learning more, you can see if you pre-qualify today.
• Cardiovascular Disease
• Type 2 Diabetes
• High Blood Pressure
This study is exploring an investigational medication that may help reduce the risk of heart-related complications.
If you’re interested in learning more, you can see if you pre-qualify today.
Conditions:
Heart Diseases
Congenital Heart Disease
Coronary Heart Disease
Ischemic Heart Disease
Heart Disease
A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Recruiting
This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure. The purpose of this study is to find out if a medicine called vicadrostat, when taken with empagliflozin, helps reduce cardiovascular risk in people with these conditions. The study will compare this combination to a placebo version of vicadrostat with empagliflozin.
Participants are put into 2 gro... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/19/2025
Locations: Dunes Clinical Research, Dakota Dunes, South Dakota
Conditions: Diabetes Mellitus, Type 2, Hypertension, Cardiovascular Diseases
A Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 Diabetes
Recruiting
The study will look at how well different doses of a new medicine called NNC0487-0111 help lower the blood sugar and body weight in people with type 2 diabetes. NNC0487-0111 is a new medicine which cannot be prescribed by doctors but has previously been tested in humans. Participants will either get NNC0487-0111, which is given as tablets or as injections, or placebo. Which treatment the participant get is decided by chance.The study will last for about 43 weeks.
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
08/10/2025
Locations: Health Concepts, Rapid City, South Dakota
Conditions: Type 2 Diabetes (T2D)
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
Recruiting
The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and delivered percutaneously into biopsied and non-biopsied contralateral kidneys in participants with T2DM and CKD.
Gender:
ALL
Ages:
Between 30 years and 80 years
Trial Updated:
07/22/2025
Locations: Dunes Clinical Research, Dakota Dunes, South Dakota
Conditions: Type 2 Diabetes Mellitus, Chronic Kidney Diseases
1 - 3 of 3